[4-(6-halo-7-substituted-2,4-dioxo-1,4-di hydro2h-quinazolin-3-yl)-phenyl]-5-chloro-thio phen-2-yl-sulfonylureas and forms and methods related thereto

Details for Australian Patent Application No. 2006311795 (hide)

Owner Portola Pharmaceuticals, Inc.

Inventors Grant, Craig M.; Mehrotra, Mukund; Scarborough, Robert M.; Cannon, Hilary; Huang, Wolin; Zhang, Xiaoming

Agent Pizzeys

Pub. Number AU-A-2006311795

PCT Pub. Number WO2007/056219

Priority 60/733,650 03.11.05 US

Filing date 3 November 2006

Wipo publication date 18 May 2007

International Classifications

A61K 31/5513 (2006.01)

A61K 31/44 (2006.01) - Non-condensed pyridines

C07D 257/04 (2006.01) Heterocyclic compounds containing rings having four nitrogen atoms as the only ring hetero atoms

Event Publications

22 May 2008 PCT application entered the National Phase

  PCT publication WO2007/056219 Priority application(s): WO2007/056219

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.

Next and Previous Patents/Applications

2006311796-5-lipoxygenase-activating protein (FLAP) inhibitors

2006311794-Heparan sulfate glycosaminoglycan lyase and uses thereof